🔎 Trials Near Me

Home › Bipolar Disorder › Illinois

Pag-aaral pangklinika para sa Bipolar Disorder sa Illinois

7 pag-aaral para sa Bipolar Disorder ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Baber Research Group, Naperville
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06229210

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • Revive Research Institute, Elgin
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06372964

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

  • Revival Research Institute, Elgin
  • Advanced Quality Medical Research, Orland Park
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07172516

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

  • Pillar Clinical Research - Chicago /ID# 272823, Chicago
  • Amr Conventions Research /ID# 272867, Warrenville
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06696755

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  • Pillar Clinical Research -Chicago, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07140913

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  • University of Chicago Medical Center, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT06740383

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.